← Back to Clinical Trials
Recruiting NCT07504367

Large Language Models Assist in Tumor MDT

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Lung Cancer
Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 25 Years
Max Age 33 Years
Start Date 2026-01-01
Completion 2026-12-31
Interventions
LLM assists in MDT report writing

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Multidisciplinary teams (MDTs) represent the gold standard for personalized tumor treatment, but they are limited by medical resources and accessibility Limitation. Although large language models (LLMs) have shown promise in medical reasoning, their multidisciplinary practicality in pan-cancer MDTs has not been fully explored. In the early stage of this project, LLMs with high clinical application efficacy were identified through benchmark tests, and an open-label randomized controlled study (RCT) was conducted based on these LLMs. The research aims to explore whether AI-assisted assistance can enhance the accuracy and writing efficiency of MDT diagnosis and treatment reports. This study intends to prospectively collect the diagnosis and treatment information of 20 patients and MDT diagnosis and treatment information. It is planned to recruit 40 junior doctors. Doctors in the intervention group will use LLM to assist in the writing of MDT reports, while doctors in the control group will use traditional information retrieval methods for the writing of MDT reports. Three clinical experts ultimately used a standardized Likert scale to conduct comprehensive and multidisciplinary scoring of the MDT reports of the intervention group and the control group. This study quantitatively compared the diagnosis and treatment quality and efficiency of the MDT AI-assisted model and the traditional model to verify the application potential of large language models in assisting tumor diagnosis and treatment.

Eligibility Criteria

Inclusion Criteria: * A junior doctor with a practicing physician qualification certificate. * Oncologists, surgeons, radiation oncologists, radiologists and pathologists with 3 to 5 years of clinical experience. * Age: 25 to 33 years old, gender not limited. * During the research period, one can participate for no less than 10 hours. * Agree to participate in this research and sign the informed consent form. Exclusion Criteria: * Have participated in the previous diagnosis and treatment of any one of the 20 cases included in the study.

Related Trials

}
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology